Brainsway

🇮🇱Israel

Country: 🇮🇱Israel

Ownership: -

Employees: 106

Market Cap: -

Website

Introduction: Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

Clinical Trials

The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease

Phase 2

Completed

Conditions: Machado Joseph Disease (SCA3)

Interventions: Device: Deep TMS

First Posted Date: 2014-01-17

Last Posted Date: 2018-01-25

Lead Sponsor: Brainsway

Target Recruit Count: 20

Registration Number: NCT02039206

Locations: 🇮🇱
Meir Medical Center, Kfar Saba, Israel

Facilitating Associative Memory Via Deep Transcranial Magnetic Stimulation to the Medial Temporal Lobe

Early Phase 1

Withdrawn

Conditions: Effect of Deep Transcranial Magnetic Stimulation on Memory

Interventions: Device: TMS

First Posted Date: 2012-05-15

Last Posted Date: 2018-01-25

Lead Sponsor: Brainsway

Registration Number: NCT01599208

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Not Applicable

Conditions: Bipolar Depression

Interventions: Device: Sham Treatment
Device: Deep TMS Treatment

First Posted Date: 2012-03-29

Last Posted Date: 2021-02-04

Lead Sponsor: Brainsway

Target Recruit Count: 120

Registration Number: NCT01566591

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
UT Southwestern Medical Center at Dallas, Dallas, Texas, United States
🇨🇦
Center for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada

and more 10 locations

Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment

Phase 1

Conditions: Mild Cognitive Impairment

Interventions: Device: SHAM Coil TMS
Device: H-Coil Deep TMS

First Posted Date: 2011-11-03

Last Posted Date: 2020-07-14

Lead Sponsor: Brainsway

Target Recruit Count: 30

Registration Number: NCT01464515

Locations: 🇮🇱
Ichilov Hospital, Neurological Department, Tel Aviv, Israel

Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children.

Phase 2

Terminated

Conditions: Autism

Interventions: Device: Transcranial Magnetic Stimulation

First Posted Date: 2011-07-06

Last Posted Date: 2018-04-17

Lead Sponsor: Brainsway

Target Recruit Count: 20

Registration Number: NCT01388179

Locations: 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel

Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)

Not Applicable

Completed

Conditions: Major Depressive Disorder, Recurrent, Unspecified
Major Depressive Disorder, Single Episode, Unspecified

Interventions: Device: H-Coil Deep TMS in combination with SSRIs

First Posted Date: 2011-05-27

Last Posted Date: 2020-07-15

Lead Sponsor: Brainsway

Target Recruit Count: 75

Registration Number: NCT01361815

Locations: 🇺🇸
Smart Brain and Health, Santa Monica, California, United States
🇺🇸
UT Southwestern Medical Center at Dallas, Dallas, Texas, United States
🇨🇦
Center for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada

and more 16 locations

Tolerability, Safety and Efficacy of the HAC-Coil Deep Transcranial Magnetic Stimulation in Medication Resistance Obsessive Compulsive Disorder (OCD) Subjects

Not Applicable

Conditions: Obsessive Compulsive Disorder

Interventions: Device: Deep TMS

First Posted Date: 2011-04-28

Last Posted Date: 2020-07-14

Lead Sponsor: Brainsway

Target Recruit Count: 40

Registration Number: NCT01343732

Locations: 🇮🇱
Sheba Medical Center, Ramat Gan, Israel

Deep Transcranial Magnetic Stimulation (DTMS) as a Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Adults

Phase 1

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Device: treatment by HLPFC coil

First Posted Date: 2010-09-09

Last Posted Date: 2020-07-14

Lead Sponsor: Brainsway

Target Recruit Count: 45

Registration Number: NCT01196910

Locations: 🇮🇱
Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease

Phase 2

Completed

Conditions: Alzheimer's Disease

Interventions: Device: TMS, H coil

First Posted Date: 2010-08-11

Last Posted Date: 2018-01-25

Lead Sponsor: Brainsway

Target Recruit Count: 45

Registration Number: NCT01179373

Locations: 🇮🇱
Merchav Clinics, Tel Aviv, Israel

Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder

Not Applicable

Completed

Conditions: Major Depressive Disorder

Interventions: Device: Brainsway H-Coil Deep TMS System (Sham treatment)
Device: Brainsway H-Coil Deep TMS System

First Posted Date: 2009-06-24

Last Posted Date: 2020-07-15

Lead Sponsor: Brainsway

Target Recruit Count: 233

Registration Number: NCT00927173

Locations: 🇺🇸
Greater Nashua Mental Health Center, Nashua, New Hampshire, United States
🇮🇱
Shalvata Mental Health Center, Hod Hasharon, Israel
🇮🇱
Hadasah Ein-Karem Medical Center, Jerusalem, Israel

and more 19 locations

Home Terms & Conditions Privacy Policy